{"id":"https://openalex.org/W4361908997","doi":"https://doi.org/10.1158/1078-0432.22451115.v1","title":"Supplementary Methods from A Phase I, Open-Label Study of Siltuximab, an Anti\u2013IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease","display_name":"Supplementary Methods from A Phase I, Open-Label Study of Siltuximab, an Anti\u2013IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361908997","doi":"https://doi.org/10.1158/1078-0432.22451115.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22451115.v1","doi":"https://doi.org/10.1158/1078-0432.22451115.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451115.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_A_Phase_I_Open-Label_Study_of_Siltuximab_an_Anti_IL-6_Monoclonal_Antibody_in_Patients_with_B-cell_Non-Hodgkin_Lymphoma_Multiple_Myeloma_or_Castleman_Disease/22451115/1/files/39902202.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_A_Phase_I_Open-Label_Study_of_Siltuximab_an_Anti_IL-6_Monoclonal_Antibody_in_Patients_with_B-cell_Non-Hodgkin_Lymphoma_Multiple_Myeloma_or_Castleman_Disease/22451115/1/files/39902202.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053481267","display_name":"Razelle Kurzrock","orcid":"https://orcid.org/0000-0003-4110-1214","observed_orcids":["https://orcid.org/0000-0003-4110-1214"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Razelle Kurzrock","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071438752","display_name":"Peter Michael Voorhees","orcid":"https://orcid.org/0000-0003-1661-718X","observed_orcids":["https://orcid.org/0000-0003-1661-718X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter M. Voorhees","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085370688","display_name":"Corey Casper","orcid":"https://orcid.org/0000-0002-3609-661X","observed_orcids":["https://orcid.org/0000-0002-3609-661X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corey Casper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013974745","display_name":"Richard R. Furman","orcid":"https://orcid.org/0000-0003-1677-7626","observed_orcids":["https://orcid.org/0000-0003-1677-7626"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Richard R. Furman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028677309","display_name":"Luis Fayad","orcid":"https://orcid.org/0000-0002-1844-5548","observed_orcids":["https://orcid.org/0000-0002-1844-5548"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luis Fayad","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023276777","display_name":"Sagar Lonial","orcid":"https://orcid.org/0000-0002-8322-9323","observed_orcids":["https://orcid.org/0000-0002-8322-9323"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sagar Lonial","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012061864","display_name":"Hossein Borghaei","orcid":"https://orcid.org/0000-0002-2577-4454","observed_orcids":["https://orcid.org/0000-0002-2577-4454"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hossein Borghaei","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028046297","display_name":"Sundar Jagannath","orcid":"https://orcid.org/0000-0003-2934-6518","observed_orcids":["https://orcid.org/0000-0003-2934-6518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sundar Jagannath","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037214066","display_name":"Lubomir Sokol","orcid":"https://orcid.org/0000-0003-0916-547X","observed_orcids":["https://orcid.org/0000-0003-0916-547X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lubomir Sokol","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009378735","display_name":"Saad Z. Usmani","orcid":"https://orcid.org/0000-0002-5484-8731","observed_orcids":["https://orcid.org/0000-0002-5484-8731"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saad Z. Usmani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049970120","display_name":"Helgi J. Van de Velde","orcid":"https://orcid.org/0009-0004-4126-8289","observed_orcids":["https://orcid.org/0009-0004-4126-8289"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helgi van de Velde","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101987321","display_name":"Xiang Qin","orcid":"https://orcid.org/0000-0003-1524-027X","observed_orcids":["https://orcid.org/0000-0003-1524-027X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiang Qin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069409328","display_name":"Thomas A. Puchalski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas A. Puchalski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114046165","display_name":"Brett M. Hall","orcid":"https://orcid.org/0009-0001-2290-0814","observed_orcids":["https://orcid.org/0009-0001-2290-0814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brett Hall","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110081","display_name":"Manjula Reddy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manjula Reddy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010388094","display_name":"Ming Qi","orcid":"https://orcid.org/0000-0001-9880-5349","observed_orcids":["https://orcid.org/0000-0001-9880-5349"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ming Qi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090044223","display_name":"Frits van Rhee","orcid":"https://orcid.org/0000-0001-9959-1282","observed_orcids":["https://orcid.org/0000-0001-9959-1282"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frits van Rhee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8589000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.8589000105857849,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.033799998462200165,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.02930000051856041,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/siltuximab","display_name":"siltuximab","score":1.0},{"id":"https://openalex.org/keywords/anti-il-6-monoclonal-antibody","display_name":"anti-IL-6 monoclonal antibody","score":0.953000009059906},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9190000295639038},{"id":"https://openalex.org/keywords/b-cell-non-hodgkin-lymphoma","display_name":"B-cell non-Hodgkin lymphoma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/castleman-disease","display_name":"Castleman disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.8889999985694885}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7293485403060913},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6860624551773071},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.647400975227356},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5470857620239258},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.47233548760414124},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.441588819026947},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4131298065185547},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3273809552192688},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.32711851596832275},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.32137060165405273},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3038187623023987}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1078-0432.22451115.v1","doi":"https://doi.org/10.1158/1078-0432.22451115.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451115.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_A_Phase_I_Open-Label_Study_of_Siltuximab_an_Anti_IL-6_Monoclonal_Antibody_in_Patients_with_B-cell_Non-Hodgkin_Lymphoma_Multiple_Myeloma_or_Castleman_Disease/22451115/1/files/39902202.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22451115","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Methods_from_A_Phase_I_Open-Label_Study_of_Siltuximab_an_Anti_IL-6_Monoclonal_Antibody_in_Patients_with_B-cell_Non-Hodgkin_Lymphoma_Multiple_Myeloma_or_Castleman_Disease/22451115","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22451115.v1","doi":"https://doi.org/10.1158/1078-0432.22451115.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1078-0432.22451115.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Methods_from_A_Phase_I_Open-Label_Study_of_Siltuximab_an_Anti_IL-6_Monoclonal_Antibody_in_Patients_with_B-cell_Non-Hodgkin_Lymphoma_Multiple_Myeloma_or_Castleman_Disease/22451115/1/files/39902202.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"sustainable_development_goals_aurora":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4361908997.pdf","grobid_xml":"https://content.openalex.org/works/W4361908997.grobid-xml"},"referenced_works_count":2,"referenced_works":["https://openalex.org/W1491876603","https://openalex.org/W2091126564"],"related_works":["https://openalex.org/W1966323553","https://openalex.org/W4240491315","https://openalex.org/W2052404185","https://openalex.org/W2050115670","https://openalex.org/W2740739001","https://openalex.org/W1995553126","https://openalex.org/W2009919126","https://openalex.org/W1999546986","https://openalex.org/W2249843386","https://openalex.org/W2064037489"],"abstract_inverted_index":{"Supplementary":[0,6],"Methods":[1],"-":[2],"PDF":[3],"file":[4],"88K,":[5],"methods":[7],"for":[8],"pharmacokinetic":[9],"analyses":[10,13],"and":[11],"pharmacodynamic":[12]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2025-10-10T00:00:00"}